ASCVD Clinical Trial - Prospective Cohort Study of Panvascular Disease

Status Active, not recruiting

Clinical Trial Summary

To construct a comprehensive big data platform for Chinese people with panvascular disease, and establish a Chinese panvascular disease oriented to guide treatment decisions Cohort and imaging, biological database; According to the clinical features, morphological structure, pathological characteristics of panvascularization, vascular age As the core of the evaluation, a standard evaluation system and a risk prediction model of intervention technology suitable for the diagnosis and treatment of patients with panvascular disease in China were established. Into the Further optimize the treatment strategies, protocols and clinical pathways for panvascular disease to improve patient prognosis and promote its application.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

ASCVD

Clinical Trial Details

NCT number	NCT06295861
Study type	Observational
Source	Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact
Status	Active, not recruiting
Phase
Start date	February 21, 2024
Completion date	December 31, 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05390892` - PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes	Phase 4
Active, not recruiting	`NCT05088759` - Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management	N/A
Not yet recruiting	`NCT04093440` - Cardiometabolic Syndrome Response to Therapeutic Lifestyle Changes	N/A
Recruiting	`NCT05611307` - Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Completed	`NCT03400800` - Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol	Phase 3
Recruiting	`NCT03606824` - Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)	N/A
Completed	`NCT03494270` - High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients	Phase 4
Recruiting	`NCT05579626` - Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)	N/A
Recruiting	`NCT06005597` - Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies	Phase 3
Terminated	`NCT04197453` - The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)
Completed	`NCT03399370` - Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol	Phase 3
Not yet recruiting	`NCT05976893` - Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer	Phase 4
Completed	`NCT03474562` - High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension	Phase 4
Completed	`NCT03814187` - Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C	Phase 3
Not yet recruiting	`NCT05858879` - Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)	N/A